Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade A 7.31 -2.40% -0.18
ETON closed down 2.4 percent on Wednesday, February 20, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical ETON trend table...

Date Alert Name Type % Chg
Feb 20 New Uptrend Bullish 0.00%
Feb 20 Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Feb 20 Upper Bollinger Band Walk Strength 0.00%
Feb 20 Above Upper BB Strength 0.00%
Feb 20 Overbought Stochastic Strength 0.00%
Feb 20 Upper Bollinger Band Touch Strength 0.00%
Feb 19 New 52 Week Closing High Bullish -2.40%
Feb 19 Expansion Breakout Bullish Swing Setup -2.40%
Feb 19 Pocket Pivot Bullish Swing Setup -2.40%
Feb 19 Volume Surge Other -2.40%

Older signals for ETON ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Medicine Health Pharmaceutical Pain Pharmaceutical Industry In China Pharmaceuticals Policy Pain Management Science And Technology In The People's Republic Of China U.S. Food And Drug Administration Ophthalmic Products Allergic Conjunctivitis Liquid Products Parenteral Nutrition Pharmaceutical Product
Is ETON a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.49
52 Week Low 5.7
Average Volume 21,909
200-Day Moving Average 0.0
50-Day Moving Average 6.2442
20-Day Moving Average 6.492
10-Day Moving Average 6.739
Average True Range 0.3072
ADX 25.41
+DI 30.5587
-DI 10.5987
Chandelier Exit (Long, 3 ATRs ) 6.5684
Chandelier Exit (Short, 3 ATRs ) 6.9216
Upper Bollinger Band 7.2178
Lower Bollinger Band 5.7662
Percent B (%b) 1.06
BandWidth 22.359827
MACD Line 0.2471
MACD Signal Line 0.1542
MACD Histogram 0.0929
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.79
Resistance 3 (R3) 7.80 7.64 7.71
Resistance 2 (R2) 7.64 7.52 7.64 7.68
Resistance 1 (R1) 7.48 7.45 7.40 7.47 7.66
Pivot Point 7.32 7.32 7.29 7.32 7.32
Support 1 (S1) 7.16 7.20 7.08 7.15 6.96
Support 2 (S2) 7.00 7.13 7.00 6.94
Support 3 (S3) 6.84 7.00 6.91
Support 4 (S4) 6.83